PTH and hypophosphatasia: Bone anabolic treatment, such as treatment with recombinant human parathyroid hormone analogs yielded debatable efficacy.26 Asfotase alfa (Strensiq, Alexion), a bone-targeted enzyme replacement therapy, was approved for the long-term treatment of pediatric-onset HPP in the United States, Europe, Canada, and Japan.